Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.
about
Novel therapeutic options in Acute Myeloid LeukemiaOutcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis.Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of theABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia.Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia.Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Autologous Transplantation for Older Adults with AMLMolecular landscape and targeted therapy of acute myeloid leukemia
P2860
Q28069889-66848112-E410-4288-A709-C1A41855236CQ33774504-BC35A586-7987-4883-8292-763CE9B865B8Q38848054-695A7A27-A6BF-4DC3-9686-8478EF81CB9FQ42325009-67D60B89-D2BB-47F0-814B-B1C8B21743AAQ47275250-496C486F-AA9C-49C0-B870-BA8FD7E47958Q47670541-01F746DE-A46D-4D0D-AA66-5FB84E3ED2FBQ47877035-C42F7554-3E32-4D0F-8E8F-384308006A6EQ48568744-E840CEE8-29CD-4BAB-9037-6599AA07F1C4Q58716610-AA355F87-54E6-4D00-8221-BDF12F69A3E7Q59130314-412B8332-451A-4422-B8C6-220A8DF6492E
P2860
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comparative value of post-remi ...... M1 and FLT3-ITD allelic ratio.
@en
Comparative value of post-remi ...... M1 and FLT3-ITD allelic ratio.
@nl
type
label
Comparative value of post-remi ...... M1 and FLT3-ITD allelic ratio.
@en
Comparative value of post-remi ...... M1 and FLT3-ITD allelic ratio.
@nl
prefLabel
Comparative value of post-remi ...... M1 and FLT3-ITD allelic ratio.
@en
Comparative value of post-remi ...... M1 and FLT3-ITD allelic ratio.
@nl
P2093
P2860
P356
P1433
P1476
Comparative value of post-remi ...... M1 and FLT3-ITD allelic ratio.
@en
P2093
B A van der Reijden
B J Biemond
B Löwenberg
E Vellenga
F E M In 't Hout
G Ossenkoppele
H C Schouten
P2860
P2888
P356
10.1038/LEU.2016.183
P577
2016-07-15T00:00:00Z
P6179
1013125306